Anmelden Kostenlos registrieren

Cotinga Pharmaceuticals Operative Marge

Was ist das Operative Marge von Cotinga Pharmaceuticals?

Operative Marge von Cotinga Pharmaceuticals, Inc. ist 0.00%

Was ist die Definition von Operative Marge?



Die operative Marge ist das Verhältnis von Betriebseinkommen zu Nettomsatz und in Prozent dargestellt.

Operating margin is an indicator of profitability and is often used to compare the profitability of companies and industries of differing sizes. Companies are collections of projects and markets, individual areas can be judged on how successful they are at adding to the corporate net profit. Not all projects are of equal size, however, and one way to adjust for size is to divide the profit by sales revenue. The resulting ratio is the percentage of sales revenue that gets 'returned' to the company as net profits after all the related costs of the activity are deducted.

Operative Marge von Unternehmen in Health Care Sektor auf TSXV im Vergleich zu Cotinga Pharmaceuticals

Was macht Cotinga Pharmaceuticals?

Cotinga Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company's lead compound is COTI-2, an oral small molecule targeting p53 a tumor suppressor gene. It also develops COTI-219, an oral small molecule compound targeting the mutant forms of KRAS without inhibiting normal KRAS functions. Cotinga Pharmaceuticals Inc. has a research collaboration with St. Vincent's University Hospital to evaluate COTI-2 in combination with eribulin in patients with triple negative metastatic breast cancer. The company was formerly known as Critical Outcome Technologies Inc. and changed its name to Cotinga Pharmaceuticals Inc. in January 2018. Cotinga Pharmaceuticals Inc. is based in Toronto, Canada.

Unternehmen mit operative marge ähnlich Cotinga Pharmaceuticals